Law, a new drug can not be marketed until it has been investigated in clinical trials and approved by the FDA to be safe and safe and effective for the intended. Statements in this press release that are not historical in nature nature forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results may contain from those in the forward-looking statements based on management’s current expectations and involve a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates the costs and delays in the development and / or FDA approval, or the failure of such approval, product candidates product candidates, the uncertainty results of clinical trials to get our inability or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of products;; competitive factors our inability to protect our patents or proprietary rights and obtain necessary rights to use third party patents and intellectual property, our business, our inability to grow our business without infringing the patents and proprietary rights to operate other, general economic conditions, the failure of products to market acceptance of win, our inability additional additional financing, technological changes, government regulation, changes in industry practice and one-time events.

And sentinel birds. We believe that integrated program integrated program crucial to the successful use of the vaccine. .. Controlled experimental studies and epidemiological reports have shown that the vaccine as part of a control strategy including strict biosecurity measures and monitoring, avian influenza outbreaks deleted. It reduces the susceptibility to infection AI herd shed while. Drastically reducing the amount of virus after challenge, which blocked transmission within the vaccinated flock – Vaccination of free-range flocks and other external birds can play an important role in the control of avian influenza, is combined with is combined with strict biosecurity, surveillance and depopulation programs, said Jim Hungerford, General Manager of Intervet UK.We look forward to continued collaboration with FDA to cooperate, as is his assessing the EYLEA BLA has been completed. . Source: Regeneron Pharmaceuticals.. Of recommendation by the Committee is be considered by FDA in its review of of the Biologics License Application for EYLEA, but rather the committee’s recommendation be not binding on the with FDA. Regeneron put a BLAC of approving the marketing in of wet AMD in the U.S. February 2011 and received a priority review by term. Under priority review by the destination Date of of a decision from the FDA on the BLA EYLEA 20th August 2011.

Regeneron Pharmaceuticals announced that it Dermatologic and Ophthalmic Drugs Advisory Committee Drug of the U.S. Food and Administration has recommend unanimity that FDA EYLEA, as a VEGF Trap-Eye is known, approved for treating of neovascular form of age related macular degeneration at a dosage of 2 milligrams all eight of select weeks of the first three doses given once a month.